Cargando…
OA05 Clinical presentation, risk factors and prognosis of MDA5-positive JDM; clinical diversity and red flags
INTRODUCTION/BACKGROUND: MDA5-positive juvenile dermatomyositis (JDM) represents a distinct clinical phenotype associated with skin and oral ulceration, milder muscle involvement and a higher incidence of interstitial lung disease (ILD) and severe rapidly progressive ILD (RP-ILD). DESCRIPTION/METHOD...
Autores principales: | McLellan, Kirsty, Al-Obaidi, Muthana, Compeyrot-Lacassagne, Sandrine, Pilkington, Clarissa, Moraitis, Elena, Papadopoulou, Charalampia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515758/ http://dx.doi.org/10.1093/rap/rkac066.005 |
Ejemplares similares
-
Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist
por: Papadopoulou, Charalampia, et al.
Publicado: (2020) -
JDM update September 2014
por: Pilkington, Clarissa
Publicado: (2014) -
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models
por: Deakin, Claire T, et al.
Publicado: (2020) -
P14 Challenges in treating anti-melanoma differentiation associated gene 5 (MDA5) antibody positive juvenile dermatomyositis (JDM) with interstitial lung disease (ILD) complicated by pneumocytis jirovecii pneumonia (PCP): a case report
por: Affendi, Sharifah Adrianna, et al.
Publicado: (2022) -
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
por: Ll Wilkinson, Meredyth G., et al.
Publicado: (2021)